Potential relationship between Sirt3 and autophagy in ovarian cancer (Review)
- Authors:
- Yuchuan Shi
- Runhua He
- Yu Yang
- Yu He
- Lei Zhan
- Bing Wei
-
Affiliations: Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China, Department of Cardiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230601, P.R. China - Published online on: August 26, 2020 https://doi.org/10.3892/ol.2020.12023
- Article Number: 162
-
Copyright: © Shi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A and Siegel RL: Ovarian cancer statistics, 2018. CA Cancer J Clin. 68:284–296. 2018. View Article : Google Scholar : PubMed/NCBI | |
Hackshaw A, Gershenson D and Ledermann J: Mucinous ovarian carcinoma. N Engl J Med. 381:e32019. View Article : Google Scholar : PubMed/NCBI | |
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wang L, Wang Q, Xu Y and Han L: Advances in the treatment of ovarian cancer using PARP inhibitors and the underlying mechanism of resistance. Curr Drug Targets. 21:167–178. 2020. View Article : Google Scholar : PubMed/NCBI | |
Hansen JM, Coleman RL and Sood AK: Targeting the tumour microenvironment in ovarian cancer. Eur J Cancer. 56:131–143. 2016. View Article : Google Scholar : PubMed/NCBI | |
Liu J, Ren Y, Hou Y, Zhang C, Wang B, Li X, Sun R and Liu J: Dihydroartemisinin induces endothelial cell autophagy through suppression of the Akt/mTOR pathway. J Cancer. 10:6057–6064. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ravikumar B, Sarkar S, Davies JE, Futter M, Garcia-Arencibia M, Green-Thompson ZW, Jimenez-Sanchez M, Korolchuk VI, Lichtenberg M, Luo S, et al: Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev. 90:1383–1435. 2010. View Article : Google Scholar : PubMed/NCBI | |
Melendez A and Neufeld TP: The cell biology of autophagy in metazoans: A developing story. Development. 135:2347–2360. 2008. View Article : Google Scholar : PubMed/NCBI | |
Boya P, González-Polo RA, Casares N, Perfettini JL, Dessen P, Larochette N, Métivier D, Meley D, Souquere S, Yoshimori T, et al: Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol. 25:1025–1040. 2005. View Article : Google Scholar : PubMed/NCBI | |
Yue Z, Jin S, Yang C, Levine AJ and Heintz N: Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA. 100:15077–15082. 2003. View Article : Google Scholar : PubMed/NCBI | |
Coppola D, Khalil F, Eschrich SA, Boulware D, Yeatman T and Wang HG: Down-regulation of Bax-interacting factor-1 in colorectal adenocarcinoma. Cancer. 113:2665–2670. 2008. View Article : Google Scholar : PubMed/NCBI | |
Boteon YL, Laing R, Mergental H, Reynolds GM, Mirza DF, Afford SC and Bhogal RH: Mechanisms of autophagy activation in endothelial cell and their targeting during normothermic machine liver perfusion. World J Gastroenterol. 23:8443–8451. 2017. View Article : Google Scholar : PubMed/NCBI | |
Nussenzweig SC, Verma S and Finkel T: The role of autophagy in vascular biology. Circ Res. 116:480–488. 2015. View Article : Google Scholar : PubMed/NCBI | |
Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH and Jung JU: Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol. 8:688–699. 2006. View Article : Google Scholar : PubMed/NCBI | |
Bishop E and Bradshaw TD: Autophagy modulation: A prudent approach in cancer treatment? Cancer Chemother Pharmacol. 82:913–922. 2018. View Article : Google Scholar : PubMed/NCBI | |
Li YJ, Lei YH, Yao N, Wang CR, Hu N, Ye WC, Zhang DM and Chen ZS: Autophagy and multidrug resistance in cancer. Chin J Cancer. 36:522017. View Article : Google Scholar : PubMed/NCBI | |
Haigis MC, Deng CX, Finley LW, Kim HS and Gius D: SIRT3 is a mitochondrial tumor suppressor: A scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Res. 72:2468–2472. 2012. View Article : Google Scholar : PubMed/NCBI | |
Sack MN and Finkel T: Mitochondrial metabolism, sirtuins, and aging. Cold Spring Harb Perspect Biol. 4:a0131022012. View Article : Google Scholar : PubMed/NCBI | |
Michan S and Sinclair D: Sirtuins in mammals: Insights into their biological function. Biochem J. 404:1–13. 2007. View Article : Google Scholar : PubMed/NCBI | |
Verdin E, Hirschey MD, Finley LW and Haigis MC: Sirtuin regulation of mitochondria: Energy production, apoptosis, and signaling. Trends Biochem Sci. 35:669–675. 2010. View Article : Google Scholar : PubMed/NCBI | |
Anderson KA and Hirschey MD: Mitochondrial protein acetylation regulates metabolism. Essays Biochem. 52:23–35. 2012. View Article : Google Scholar : PubMed/NCBI | |
Alhazzazi TY, Kamarajan P, Joo N, Huang JY, Verdin E, D'Silva NJ and Kapila YL: Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 117:1670–1678. 2011. View Article : Google Scholar : PubMed/NCBI | |
Shi T, Wang F, Stieren E and Tong Q: SIRT3, a mitochondrial sirtuin deacetylase, regulates mitochondrial function and thermogenesis in brown adipocytes. J Biol Chemy. 280:13560–13567. 2005. View Article : Google Scholar | |
Kong X, Wang R, Xue Y, Liu X, Zhang H, Chen Y, Fang F and Chang Y: Sirtuin 3, a new target of PGC-1alpha, plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS One. 5:e117072010. View Article : Google Scholar : PubMed/NCBI | |
Guarente L: Introduction: Sirtuins in aging and diseases. Methods Mol Biol. 1077:3–10. 2013. View Article : Google Scholar : PubMed/NCBI | |
Resendis-Antonio O, Checa A and Encarnacion S: Modeling core metabolism in cancer cells: Surveying the topology underlying the Warburg effect. PLoS One. 5:e123832010. View Article : Google Scholar : PubMed/NCBI | |
Madhok BM, Yeluri S, Perry SL, Hughes TA and Jayne DG: Targeting glucose metabolism: An emerging concept for anticancer therapy. Am J Clin Oncol. 34:628–635. 2011. View Article : Google Scholar : PubMed/NCBI | |
Hirschey MD, Shimazu T, Goetzman E, Jing E, Schwer B, Lombard DB, Grueter CA, Harris C, Biddinger S and Ilkayeva OR: SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature. 464:121–125. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bagul PK, Katare PB, Bugga P, Dinda AK and Banerjee SK: SIRT-3 modulation by resveratrol improves mitochondrial oxidative phosphorylation in diabetic heart through deacetylation of TFAM. Cells. 7:2352018. View Article : Google Scholar | |
Dai SH, Chen T, Li X, Yue KY, Luo P, Yang LK, Zhu J, Wang YH, Fei Z and Jiang XF: Sirt3 confers protection against neuronal ischemia by inducing autophagy: Involvement of the AMPK-mTOR pathway. Free Radic Biol Med. 108:345–353. 2017. View Article : Google Scholar : PubMed/NCBI | |
Pi H, Xu S, Reiter RJ, Guo P, Zhang L, Li Y, Li M, Cao Z, Tian L, Xie J, et al: SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin. Autophagy. 11:1037–1051. 2015. View Article : Google Scholar : PubMed/NCBI | |
Li Y, Ma Y, Song L, Yu L, Zhang L, Zhang Y, Xing Y, Yin Y and Ma H: SIRT3 deficiency exacerbates p53/Parkin-mediated mitophagy inhibition and promotes mitochondrial dysfunction: Implication for aged hearts. Int J Mol Med. 41:3517–3526. 2018.PubMed/NCBI | |
Edgett BA, Hughes MC, Matusiak JB, Perry CG, Simpson CA and Gurd BJ: SIRT3 gene expression but not SIRT3 subcellular localization is altered in response to fasting and exercise in human skeletal muscle. Exp Physiol. 101:1101–1113. 2016. View Article : Google Scholar : PubMed/NCBI | |
Chen Y, Fu LL, Wen X, Wang XY, Liu J, Cheng Y and Huang J: Sirtuin-3 (SIRT3), a therapeutic target with oncogenic and tumor-suppressive function in cancer. Cell Death Dis. 5:e10472014. View Article : Google Scholar : PubMed/NCBI | |
Dong XC, Jing LM, Wang WX and Gao YX: Down-regulation of SIRT3 promotes ovarian carcinoma metastasis. Biochem Biophys Res Commun. 475:245–250. 2016. View Article : Google Scholar : PubMed/NCBI | |
Yang Y, Cao Y, Chen L, Liu F, Qi Z, Cheng X and Wang Z: Cryptotanshinone suppresses cell proliferation and glucose metabolism via STAT3/SIRT3 signaling pathway in ovarian cancer cells. Cancer Med. 7:4610–4618. 2018. View Article : Google Scholar : PubMed/NCBI | |
Xiang XY, Kang JS, Yang XC, Su J, Wu Y, Yan XY, Xue YN, Xu Y, Liu YH, Yu CY, et al: SIRT3 participates in glucose metabolism interruption and apoptosis induced by BH3 mimetic S1 in ovarian cancer cells. Int J Oncol. 49:773–784. 2016. View Article : Google Scholar : PubMed/NCBI | |
Signorile A, De Rasmo D, Cormio A, Musicco C, Rossi R, Fortarezza F, Palese LL, Loizzi V, Resta L, Scillitani G, et al: Human ovarian cancer tissue exhibits increase of mitochondrial biogenesis and cristae remodeling. Cancers (Basel). 11:13502019. View Article : Google Scholar | |
Hou L, Wang R, Wei H, Li S, Liu L, Lu X, Yu H and Liu Z: ABT737 enhances ovarian cancer cells sensitivity to cisplatin through regulation of mitochondrial fission via Sirt3 activation. Life Sci. 232:1165612019. View Article : Google Scholar : PubMed/NCBI | |
Li J, Yue H, Yu H, Lu X and Xue X: Development and validation of SIRT3-related nomogram predictive of overall survival in patients with serous ovarian cancer. J Ovarian Res. 12:472019. View Article : Google Scholar : PubMed/NCBI | |
Yang Y and Klionsky DJ: Autophagy and disease: Unanswered questions. Cell Death Differ. 27:858–871. 2020. View Article : Google Scholar : PubMed/NCBI | |
Wilde L, Tanson K, Curry J and Martinez-Outschoorn U: Autophagy in cancer: A complex relationship. Biochem J. 475:1939–1954. 2018. View Article : Google Scholar : PubMed/NCBI | |
Glick D, Barth S and Macleod KF: Autophagy: Cellular and molecular mechanisms. J Pathol. 221:3–12. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bednarczyk M, Zmarzly N, Grabarek B, Mazurek U and Muc-Wierzgon M: Genes involved in the regulation of different types of autophagy and their participation in cancer pathogenesis. Oncotarget. 9:34413–34428. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhi X, Feng W, Rong Y and Liu R: Anatomy of autophagy: From the beginning to the end. Cell Mol Life SciS. 75:815–831. 2018. View Article : Google Scholar | |
Burman C and Ktistakis NT: Autophagosome formation in mammalian cells. Semin Immunopathol. 32:397–413. 2010. View Article : Google Scholar : PubMed/NCBI | |
Schaeffer V, Lavenir I, Ozcelik S, Tolnay M, Winkler DT and Goedert M: Stimulation of autophagy reduces neurodegeneration in a mouse model of human tauopathy. Brain. 135:2169–2177. 2012. View Article : Google Scholar : PubMed/NCBI | |
Liao X, Sluimer JC, Wang Y, Subramanian M, Brown K, Pattison JS, Robbins J, Martinez J and Tabas I: Macrophage autophagy plays a protective role in advanced atherosclerosis. Cell Metab. 15:545–553. 2012. View Article : Google Scholar : PubMed/NCBI | |
Dikic I, Johansen T and Kirkin V: Selective autophagy in cancer development and therapy. Cancer Res. 70:3431–3434. 2010. View Article : Google Scholar : PubMed/NCBI | |
Kim JJ, Lee HM, Shin DM, Kim W, Yuk JM, Jin HS, Lee SH, Cha GH, Kim JM, Lee ZW, et al: Host cell autophagy activated by antibiotics is required for their effective antimycobacterial drug action. Cell Host Microbe. 11:457–468. 2012. View Article : Google Scholar : PubMed/NCBI | |
White E and DiPaola RS: The double-edged sword of autophagy modulation in cancer. Clin Cancer Res. 15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI | |
Pu Z, Wu L, Guo Y, Li G, Xiang M, Liu L, Zhan H, Zhou X and Tan H: LncRNA MEG3 contributes to adenosine-induced cytotoxicity in hepatoma HepG2 cells by downregulated ILF3 and autophagy inhibition via regulation PI3K-AKT-mTOR and beclin-1 signaling pathway. J Cell Biochem. 120:18172–18185. 2019. View Article : Google Scholar : PubMed/NCBI | |
Li X, Lou X, Xu S, Wang Q, Shen M and Miao J: Knockdown of miR-372 Inhibits nerve cell apoptosis induced by spinal cord ischemia/reperfusion injury via enhancing autophagy by Up-regulating Beclin-1. J Mol Neurosci. 66:437–444. 2018. View Article : Google Scholar : PubMed/NCBI | |
Cai M, Hu Z, Liu J, Gao J, Liu C, Liu D, Tan M, Zhang D and Lin B: Beclin 1 expression in ovarian tissues and its effects on ovarian cancer prognosis. Int J Mol Sci. 15:5292–5303. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hennessy BT, Smith DL, Ram PT, Lu Y and Mills GB: Exploiting the PI3K/AKT pathway for cancer drug discovery. Nat Rev Drug Discov. 4:988–1004. 2005. View Article : Google Scholar : PubMed/NCBI | |
Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C and Gonzalez-Baron M: PI3K/Akt signalling pathway and cancer. Cancer Treat Rev. 30:193–204. 2004. View Article : Google Scholar : PubMed/NCBI | |
Carnero A, Blanco-Aparicio C, Renner O, Link W and Leal JF: The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 8:187–198. 2008. View Article : Google Scholar : PubMed/NCBI | |
Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P and Ogier-Denis E: The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem. 276:35243–35246. 2001. View Article : Google Scholar : PubMed/NCBI | |
Li H, Zeng J and Shen K: PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer. Arch Gynecol Obstet. 290:1067–1078. 2014. View Article : Google Scholar : PubMed/NCBI | |
Hu L, Zaloudek C, Mills GB, Gray J and Jaffe RB: In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res. 6:880–886. 2000.PubMed/NCBI | |
Engel JB, Schönhals T, Häusler S, Krockenberger M, Schmidt M, Horn E, Köster F, Dietl J, Wischhusen J and Honig A: Induction of programmed cell death by inhibition of AKT with the alkylphosphocholine perifosine in in vitro models of platinum sensitive and resistant ovarian cancers. Arch Gynecol Obstet. 283:603–610. 2011. View Article : Google Scholar : PubMed/NCBI | |
Sun H, Yu T and Li J: Co-administration of perifosine with paclitaxel synergistically induces apoptosis in ovarian cancer cells: More than just AKT inhibition. Cancer Lett. 310:118–128. 2011. View Article : Google Scholar : PubMed/NCBI | |
Yu Y, Hall T, Eathiraj S, Wick MJ, Schwartz B and Abbadessa G: In-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitor. Anticancer Drugs. 28:503–513. 2017. View Article : Google Scholar : PubMed/NCBI | |
Ichikawa K, Abe T, Nagase H, Saito H, Fujita R, Okada M, Yonekura K, Shimomura T and Utsugi T: Abstract C177: TAS-117, a highly selective non-ATP competitive inhibitor of AKT demonstrated antitumor activity in combination with chemotherapeutic agents and molecular targeted drugs. Mol Cancer Ther. 12 (Suppl 11):C1772013. | |
Son Y, An Y, Jung J, Shin S, Park I, Gwak J, Ju BG, Chung YH, Na M and Oh S: Protopine isolated from Nandina domestica induces apoptosis and autophagy in colon cancer cells by stabilizing p53. Phytother Res. 33:1689–1696. 2019. View Article : Google Scholar : PubMed/NCBI | |
Brooks CL and Gu W: Ubiquitination, phosphorylation and acetylation: The molecular basis for p53 regulation. Curr Opin Cell Biol. 15:164–171. 2003. View Article : Google Scholar : PubMed/NCBI | |
Brooks CL and Gu W: The impact of acetylation and deacetylation on the p53 pathway. Protein Cell. 2:456–462. 2011. View Article : Google Scholar : PubMed/NCBI | |
Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S and Levine AJ: The regulation of AMPK beta1, TSC2, and PTEN expression by p53: Stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res. 67:3043–3053. 2007. View Article : Google Scholar : PubMed/NCBI | |
Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, Gasco M, Garrone O, Crook T and Ryan KM: DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell. 126:121–134. 2006. View Article : Google Scholar : PubMed/NCBI | |
Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, Criollo A, Morselli E, Zhu C, Harper F, et al: Regulation of autophagy by cytoplasmic p53. Nat Cell Biol. 10:676–687. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chen N and Karantza-Wadsworth V: Role and regulation of autophagy in cancer. Biochim Biophys Acta. 1793:1516–1523. 2009. View Article : Google Scholar : PubMed/NCBI | |
Liang M and Zhao J: Protein expressions of AIB1, p53 and Bcl-2 in epithelial ovarian cancer and their correlations with the clinical pathological features and prognosis. Eur Rev Med Pharmacol Sci. 22:5134–5139. 2018.PubMed/NCBI | |
Chen YN, Ren CC, Yang L, Nai MM, Xu YM, Zhang F and Liu Y: MicroRNA let7d5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1. Int J Oncol. 54:1771–1784. 2019.PubMed/NCBI | |
Cho CS, Lombard DB and Lee JH: SIRT3 as a regulator of hepatic autophagy. Hepatology. 66:700–702. 2017. View Article : Google Scholar : PubMed/NCBI | |
Gao J, Feng Z, Wang X, Zeng M, Liu J, Han S, Xu J, Chen L, Cao K, Long J, et al: SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ. 25:229–240. 2018. View Article : Google Scholar : PubMed/NCBI | |
Liu H, Li S, Liu X, Chen Y and Deng H: SIRT3 overexpression inhibits growth of kidney tumor cells and enhances mitochondrial biogenesis. J Proteome Res. 17:3143–3152. 2018. View Article : Google Scholar : PubMed/NCBI | |
Shi H, Deng HX, Gius D, Schumacker PT, Surmeier DJ and Ma YC: Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress. Hum Mol Genet. 26:1915–1926. 2017. View Article : Google Scholar : PubMed/NCBI | |
Duran A, Amanchy R, Linares JF, Joshi J, Abu-Baker S, Porollo A, Hansen M, Moscat J and Diaz-Meco MT: p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell. 44:134–146. 2011. View Article : Google Scholar : PubMed/NCBI | |
Wang ZG, Li H, Huang Y, Li R, Wang XF, Yu LX, Guang XQ, Li L, Zhang HY, Zhao YZ, et al: Nerve growth factor-induced Akt/mTOR activation protects the ischemic heart via restoring autophagic flux and attenuating ubiquitinated protein accumulation. Oncotarget. 8:5400–5413. 2017. View Article : Google Scholar : PubMed/NCBI | |
Ma Q, Zhang Z, Shim JK, Venkatraman TN, Lascola CD, Quinones QJ, Mathew JP, Terrando N and Podgoreanu MV: Annexin A1 bioactive peptide promotes resolution of neuroinflammation in a rat model of exsanguinating cardiac arrest treated by emergency preservation and resuscitation. Front Neurosci. 13:6082019. View Article : Google Scholar : PubMed/NCBI | |
Tong W, Ju L, Qiu M, Xie Q, Chen Y, Shen W, Sun W, Wang W and Tian J: Liraglutide ameliorates non-alcoholic fatty liver disease by enhancing mitochondrial architecture and promoting autophagy through the SIRT1/SIRT3-FOXO3a pathway. Hepatol Res. 46:933–943. 2016. View Article : Google Scholar : PubMed/NCBI | |
Zhang M, Lin J, Wang S, Cheng Z, Hu J, Wang T, Man W, Yin T, Guo W, Gao E, et al: Melatonin protects against diabetic cardiomyopathy through Mst1/Sirt3 signaling. J Pineal Res. May 8–2017.(Epub ahead of print). doi: 10.1111/jpi.12418. View Article : Google Scholar | |
Xiang X, Huang J, Song S, Wang Y, Zeng Y, Wu S and Ruan Y: 17β-estradiol inhibits H2O2-induced senescence in HUVEC cells through upregulating SIRT3 expression and promoting autophagy. Biogerontology. Mar 14–2020.(Epub ahead of print). doi: 10.1007/s10522-020-09868-w. View Article : Google Scholar | |
Zhang Y, Kwok-Shing Ng P, Kucherlapati M, Chen F, Liu Y, Tsang YH, de Velasco G, Jeong KJ, Akbani R, Hadjipanayis A, et al: A pan-cancer proteogenomic atlas of PI3K/AKT/mTOR pathway alterations. Cancer Cell. 31:820–832.e3. 2017. View Article : Google Scholar : PubMed/NCBI | |
Sun Y, Huang YH, Huang FY, Mei WL, Liu Q, Wang CC, Lin YY, Huang C, Li YN, Dai HF and Tan GH: 3′-epi-12β-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells. Theranostics. 8:2044–2060. 2018. View Article : Google Scholar : PubMed/NCBI | |
Yang Q, Du WW, Wu N, Yang W, Awan FM, Fang L, Ma J, Li X, Zeng Y, Yang Z, et al: A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation. Cell Death Differ. 24:1609–1620. 2017. View Article : Google Scholar : PubMed/NCBI | |
Quan Y, Wang N, Chen Q, Xu J, Cheng W, Di M, Xia W and Gao WQ: SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway. Oncotarget. 6:26494–26507. 2015. View Article : Google Scholar : PubMed/NCBI | |
Wang G, Wang JJ, Wang YZ, Feng S, Jing G and Fu XL: Myricetin nanoliposomes induced SIRT3-mediated glycolytic metabolism leading to glioblastoma cell death. Artif Cells Nanomed Biotechnol. 46 (Suppl 3):S180–S191. 2018. View Article : Google Scholar : PubMed/NCBI | |
Diotte NM, Xiong Y, Gao J, Chua BH and Ho YS: Attenuation of doxorubicin-induced cardiac injury by mitochondrial glutaredoxin 2. Biochim Biophys Acta. 1793:427–438. 2009. View Article : Google Scholar : PubMed/NCBI | |
Zhao M and Klionsky DJ: AMPK-dependent phosphorylation of ULK1 induces autophagy. Cell Metab. 13:119–120. 2011. View Article : Google Scholar : PubMed/NCBI | |
Garcia D and Shaw RJ: AMPK: Mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell. 66:789–800. 2017. View Article : Google Scholar : PubMed/NCBI | |
Inoki K, Kim J and Guan KL: AMPK and mTOR in cellular energy homeostasis and drug targets. Annu Rev Pharmacol Toxicol. 52:381–400. 2012. View Article : Google Scholar : PubMed/NCBI | |
Kim J, Kundu M, Viollet B and Guan KL: AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI | |
Zhao W, Zhang L, Chen R, Lu H, Sui M, Zhu Y and Zeng L: SIRT3 protects against acute kidney injury via AMPK/mTOR-regulated autophagy. Front Physiol. 9:15262018. View Article : Google Scholar : PubMed/NCBI | |
Inoki K, Zhu T and Guan KL: TSC2 mediates cellular energy response to control cell growth and survival. Cell. 115:577–590. 2003. View Article : Google Scholar : PubMed/NCBI | |
Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE and Shaw RJ: AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell. 30:214–226. 2008. View Article : Google Scholar : PubMed/NCBI | |
Shackelford DB and Shaw RJ: The LKB1-AMPK pathway: Metabolism and growth control in tumour suppression. Nat Rev Cancer. 9:563–575. 2009. View Article : Google Scholar : PubMed/NCBI | |
Zhang M, Deng YN, Zhang JY, Liu J, Li YB, Su H and Qu QM: SIRT3 protects rotenone-induced injury in SH-SY5Y cells by promoting autophagy through the LKB1-AMPK-mTOR pathway. Aging Dis. 9:273–286. 2018. View Article : Google Scholar : PubMed/NCBI | |
Bazhin AV, Philippov PP and Karakhanova S: Reactive oxygen species in cancer biology and anticancer therapy. Oxid Med Cell Longev. 2016:41978152016. View Article : Google Scholar : PubMed/NCBI | |
Shi L, Zhang T, Zhou Y, Zeng X, Ran L, Zhang Q, Zhu J and Mi M: Dihydromyricetin improves skeletal muscle insulin sensitivity by inducing autophagy via the AMPK-PGC-1alpha-Sirt3 signaling pathway. Endocrine. 50:378–389. 2015. View Article : Google Scholar : PubMed/NCBI | |
Lv W, Sui L, Yan X, Xie H, Jiang L, Geng C, Li Q, Yao X, Kong Y and Cao J: ROS-dependent Atg4 upregulation mediated autophagy plays an important role in Cd-induced proliferation and invasion in A549 cells. Chem Biol Interact. 279:136–144. 2018. View Article : Google Scholar : PubMed/NCBI | |
Li ZY, Yang Y, Ming M and Liu B: Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem Biophys Res Commun. 414:5–8. 2011. View Article : Google Scholar : PubMed/NCBI | |
Xia C, He Z, Liang S, Chen R, Xu W, Yang J, Xiao G and Jiang S: Metformin combined with nelfinavir induces SIRT3/mROS-dependent autophagy in human cervical cancer cells and xenograft in nude mice. Eur J Pharmacol. 848:62–69. 2019. View Article : Google Scholar : PubMed/NCBI | |
Qiu X, Brown K, Hirschey MD, Verdin E and Chen D: Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 12:662–667. 2010. View Article : Google Scholar : PubMed/NCBI | |
Tan WX, Xu TM, Zhou ZL, Lv XJ, Liu J, Zhang WJ and Cui MH: TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer. Oncol Rep. 42:1343–1354. 2019. | |
Qiu S, Sun L, Zhang Y and Han S: Downregulation of BAG3 attenuates cisplatin resistance by inhibiting autophagy in human epithelial ovarian cancer cells. Oncol Lett. 18:1969–1978. 2019.PubMed/NCBI | |
Xie Z, Guo Z, Wang Y, Lei J and Yu J: Protocatechuic acid inhibits the growth of ovarian cancer cells by inducing apoptosis and autophagy. Phytother Res. 32:2256–2263. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhu H, Diao S, Lim V, Hu L and Hu J: FAM83D inhibits autophagy and promotes proliferation and invasion of ovarian cancer cells via PI3K/AKT/mTOR pathway. Acta Biochim Biophys Sin (Shanghai). 51:509–516. 2019. View Article : Google Scholar : PubMed/NCBI | |
Wu Y, Gao WN, Xue YN, Zhang LC, Zhang JJ, Lu SY, Yan XY, Yu HM, Su J and Sun LK: SIRT3 aggravates metformin-induced energy stress and apoptosis in ovarian cancer cells. Exp Cell Res. 367:137–149. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zou G, Bai J, Li D and Chen Y: Effect of metformin on the proliferation, apoptosis, invasion and autophagy of ovarian cancer cells. Exp Ther Med. 18:2086–2094. 2019.PubMed/NCBI | |
Li X, Su J, Xia M, Li H, Xu Y, Ma C, Ma L, Kang J, Yu H, Zhang Z and Sun L: Caspase-mediated cleavage of Beclin1 inhibits autophagy and promotes apoptosis induced by S1 in human ovarian cancer SKOV3 cells. Apoptosis. 21:225–238. 2016. View Article : Google Scholar : PubMed/NCBI | |
Liu N, Xu Y, Sun JT, Su J, Xiang XY, Yi HW, Zhang ZC and Sun LK: The BH3 mimetic S1 induces endoplasmic reticulum stress-associated apoptosis in cisplatin-resistant human ovarian cancer cells although it activates autophagy. Oncol Rep. 30:2677–2684. 2013. View Article : Google Scholar : PubMed/NCBI | |
Yang X, Xiang X, Xia M, Su J, Wu Y, Shen L, Xu Y and Sun L: Inhibition of JNK3 promotes apoptosis induced by BH3 mimetic S1 in chemoresistant human ovarian cancer cells. Anat Rec (Hoboken). 298:386–395. 2015. View Article : Google Scholar : PubMed/NCBI | |
Yang Y, Li N, Chen T, Zhang C, Li J, Liu L, Qi Y, Zheng X, Zhang C and Bu P: Sirt3 promotes sensitivity to sunitinib-induced cardiotoxicity via inhibition of GTSP1/JNK/autophagy pathway in vivo and in vitro. Arch Toxicol. 93:3249–3260. 2019. View Article : Google Scholar : PubMed/NCBI |